Vanda Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.About VNDA
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.
CEOMihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees368
Employees368
HeadquartersWashington, District of Columbia
HeadquartersWashington, District of Columbia
Founded2002
Founded2002
Employees368
Employees368
VNDA Key Statistics
Market cap247.84M
Market cap247.84M
Price-Earnings ratio-13.08
Price-Earnings ratio-13.08
Dividend yield—
Dividend yield—
Average volume484.71K
Average volume484.71K
High today$4.28
High today$4.28
Low today$4.20
Low today$4.20
Open price$4.27
Open price$4.27
Volume468.92K
Volume468.92K
52 Week high$6.75
52 Week high$6.75
52 Week low$3.85
52 Week low$3.85
VNDA News
TipRanks 2d
Vanda says FDA ‘unlawfully’ delaying hearingVanda Pharmaceuticals (VNDA) stated that “FDA bureaucrats have committed to delay Vanda’s request for a hearing on the approvability of tradipitant for gastropa...